G

Guobang Pharma Ltd
SSE:605507

Watchlist Manager
Guobang Pharma Ltd
SSE:605507
Watchlist
Price: 20.48 CNY -0.15% Market Closed
Market Cap: 11.4B CNY
Have any thoughts about
Guobang Pharma Ltd?
Write Note

Guobang Pharma Ltd
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Guobang Pharma Ltd
PP&E Gross Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
G
Guobang Pharma Ltd
SSE:605507
PP&E Gross
ÂĄ4.3B
CAGR 3-Years
23%
CAGR 5-Years
29%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
PP&E Gross
ÂĄ3.3B
CAGR 3-Years
-2%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
PP&E Gross
ÂĄ854.4m
CAGR 3-Years
12%
CAGR 5-Years
26%
CAGR 10-Years
11%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
PP&E Gross
ÂĄ7B
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
16%
Yunnan Baiyao Group Co Ltd
SZSE:000538
PP&E Gross
ÂĄ3.6B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
8%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
PP&E Gross
ÂĄ534.8m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Guobang Pharma Ltd's PP&E Gross?
PP&E Gross
4.3B CNY

Based on the financial report for Dec 31, 2023, Guobang Pharma Ltd's PP&E Gross amounts to 4.3B CNY.

What is Guobang Pharma Ltd's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
29%

Over the last year, the PP&E Gross growth was 30%. The average annual PP&E Gross growth rates for Guobang Pharma Ltd have been 23% over the past three years , 29% over the past five years .

Back to Top